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Approximately 325,000 surgical site infec-
tions occur each year in the United States,
generating additional hospital costs in excess of
$1 billion (1,2). Surgical site infection is also a
major cause of increased hospital stay and death
(3-6). Surgical site infection rates are an
established measure of quality of clinical care
(2,7), and reliable surveillance data are the
foundation of effective infection control pro-
grams. However, to interpret surgical site
infection surveillance rates, an effective risk
adjustment system is needed. The National
Nosocomial Infections Surveillance (NNIS)
program uses a risk adjustment system for
surgical site infection that includes three equally
weighted variables: wound class, procedure
duration, and the American Society of Anesthesi-
ologists (ASA) score (8). The ASA score, a
preoperative rating assigned to each patient, is
a measure of the patient’s general health status
and coexisting conditions (9). Scores range
from 1, representing a healthy person, to 5,
representing a patient not expected to survive
longer than 24 hours. The NNIS risk index
assigns one point to patients with an ASA score
>3. The ASA score is the only marker of
coexisting conditions in the NNIS risk index.
Although the ASA score predicts surgical site
infection, length of hospital stay, and risk for
death (9-11), it is limited as a risk adjustment
measure because of its subjectivity and poor
inter-rater reliability (12-14). In a study in which
304 anesthesiologists assigned ASA scores to 10
hypothetical patients, the mean number of
patients rated identically by the expert panel was
5.9 (13). The range of ASA scores is limited to five
potential values; furthermore, there is often
limited variation among patients undergoing
similar procedures. Finally, the ASA score is not
always available or easily accessible. It is
typically not assigned for outpatient surgical
procedures or procedures not attended by an
anesthesiologist. An alternative rating system
for coexisting diseases that does not have these
limitations is needed.
A supplemental or alternative measure of a
patient’s underlying risk for surgical site
infection is the chronic disease score, a measure
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The system used by the National Nosocomial Infection Surveillance (NNIS)
program to measure risk of surgical site infection uses a score of  3 on the American
Society of Anesthesiologists (ASA)-physical status scale as a measure of underlying
illness. The chronic disease score measures health status as a function of age, sex, and
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prediction of infection by the NNIS risk index and augmented the ASA score for risk
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that predicts death, hospitalization, and use of
health resources (15-17). For an individual
patient, the chronic disease score is derived from
the patient’s age, sex, and presence or absence of
each of 29 chronic diseases, which are inferred
from ambulatory pharmacy dispensing records
for the preceding 6 or 12 months.
We studied the relationships between
surgical site infection and the chronic disease
score and ASA score and evaluated whether the
chronic disease score might improve or augment
the NNIS risk index for surgical site infection.
Methods
Study Design
This nested case-control study involved cases
of surgical site infection confirmed within 30 days
after surgery, as well as individually matched
controls. The study population was drawn from
two patient cohorts (18,19) for which postopera-
tive infection status and risk factors had been
rigorously established. Data sources and meth-
ods of identifying surgical site infections have
been described (18,19). We identified all adult
members of the staff model component of
Harvard Pilgrim Health Care (a mixed-model
health maintenance organization) who under-
went nonobstetric surgeries at Brigham and
Women’s Hospital from February 14, 1992,
through March 6, 1993, and from May 19, 1997,
through October 29, 1998. More than one surgery
could be included for the same patient. Surgeries
were excluded from analysis if they were
performed on the same anatomic site within 3
months of prior surgery, on different sites but <1
month apart, or with infection as the indication
for surgery. Patients were continuous members
of the health-care plan for the 6 months before
surgery and had prescription drug benefits. The
NNIS classification system was used to catego-
rize procedures on the basis of the International
Classification of Diseases, 9th Edition (ICD-9)
code (20). Surgical site infections occurring in the
hospital or after discharge were identified by
screening automated claims and electronic
medical record data (18,19) and were confirmed
by chart review according to NNIS criteria.
Controls were selected from patients who did
not have a surgical site infection. Two controls
were matched to each case from procedures
performed within the following 6 weeks. In
selecting controls, the greatest weight was given
to matching procedure type (ICD-9 code, NNIS
procedure, or NNIS procedure group), then to
sex, age, and duration of procedure. The chronic
disease score was calculated on the basis of
prescriptions dispensed for the 6 months before
surgery, available from an automated pharmacy
record that captures essentially all pharmacy
dispensing for health-plan members (17).
Chronic disease scores have been reported on the
basis of 6 or 12 months of pharmacy dispensing
data. For this study, we used data from the 6
months before each patient’s surgery, to
minimize the number of exclusions caused by
incomplete data. We used weights for disease
classes derived for 12 months of data, because
these provided a more current assessment of the
importance of disease classes and because our
emphasis was on the relative ranking of infected
and uninfected patients, rather than on absolute
risk prediction. We also computed the admission
chronic disease score (a variant of the chronic
disease score based solely on hospital pharmacy
dispensing activity on the day of admission) by
using an automated hospital database that
captures all medications dispensed to hospital-
ized patients.
The ASA score, type of anesthesia adminis-
tered, and emergency nature of the operative
procedure were obtained by chart review. A
procedure was considered an emergency if it was
coded as such by the surgeon on the postoperative
surgical summary sheets. Age, sex, procedure
type, procedure duration, and wound class were
obtained from automated databases.
Data Analysis
The chronic disease score was studied as a
continuous, ordinal, and dichotomous predictor.
As an ordinal predictor, the score was divided
into quartiles. All quartiles were entered into a
conditional logistic regression model. The effects
were plotted to determine if they had increased in
a linear fashion.
Choosing a breakpoint to create a dichoto-
mous chronic disease score variable was
problematic because of the overfitting that would
be introduced if the breakpoint were based on the
result of a single conditional logistic regression
model. Therefore, we generated 500 bootstrap
samples, each the same size as the entire dataset,
and selected by resampling from our entire
dataset. Then, using conditional logistic regres-
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after the data were controlled for age, sex,
duration of surgery, and emergency surgery, we
arrived at the best chronic disease score for each
of the samples. A forward selection process was
used to build the models; this process selected the
chronic disease score, by producing 500 break-
point values, of which the median value was
chosen (21,22). In addition, the distribution of the
500 values was used to assess the stability and
robustness of the final breakpoint. To determine
a breakpoint for the admission chronic disease
score, we followed the same procedure, except
logistic regression was used rather than
conditional logistic regression.
The ASA score was evaluated as both a 5-
level ordinal variable, with values of 1,2,3,4, and
5, and as a dichotomous variable (ASA  >3 and
ASA <3, corresponding to the NNIS scoring
system). The unadjusted relationship between
chronic disease score and surgical site infection
was analyzed by paired t test. All other analyses
of the relationships between the chronic disease
score and surgical site infection and between
ASA and surgical site infection were performed
by using conditional logistic regression. The
unadjusted relationships between the admission
chronic disease score and surgical site infection
were analyzed with the Wilcoxon rank sum test
and Fisher’s exact test, because the cases of
infection and their controls were no longer
paired. Missing ASA scores (they were typically
not available for ambulatory surgery procedures)
were coded as dummy variables. Univariate
relationships between other dichotomous vari-
ables and surgical site infection were analyzed
with Cochran-Mantel-Haenszel summary statis-
tics (for matched data) or Fisher’s exact test (for
unmatched data).
Relationships between continuous and ordi-
nal variables were analyzed by conditional
logistic regression for matched data and by
Student’s  t test, Wilcoxon rank sum test, or
logistic regression for unmatched data. The
linearity assumption for continuous and ordinal
predictors was examined in the same way as for
the continuous chronic disease score. The
relationships between the chronic disease score,
the admission chronic disease score, and the ASA
score were analyzed by Spearman correlation.
For matched data, multivariate analyses assess-
ing surgical site infection as the outcome were
performed by conditional logistic regression. The
following variables were included in the matched
multivariate models: the chronic disease score,
ASA score, type of anesthesia, emergency pro-
cedure vs. regular procedure, procedure dura-
tion, and wound class. The ability of these models
to discriminate between infected and uninfected
patients was compared by chi-square test to
analyze differences in -2 log likelihood values.
Interaction terms between the chronic
disease score and all other variables in the final
model were evaluated and retained if they were
statistically significant (p<0.05). For the un-
matched analysis involving the admission
chronic disease score, logistic regression was
used. The following variables were included in
the multivariate models: the admission chronic
disease score, ASA score, sex, age, type of
anesthesia, emergency procedure vs. regular
procedure, procedure duration, and wound class.
These regression models were analyzed for
overfitting by the bootstrap method (1,000
bootstrap samples chosen as described).
An NNIS risk index score was calculated for
each patient by assigning one point each for a
contaminated wound, an ASA score >3, and
surgical procedures lasting longer than the
NNIS-derived 75th percentile for the duration of
the procedure (23). Patients without an assigned
ASA score were assumed to have a score <3,
because more than two thirds of these surgeries
were performed as outpatient procedures.
Two variant scores were also computed; in
one of these, a chronic disease score  >5,000 was
substituted for ASA score  >3, and in the other, a
point was added to the NNIS score for a chronic
disease score >5,000. The ability of these three
scores to discriminate between infected and
uninfected patients was compared by using
unconditional logistic regression and the chi-
square test to analyze differences in -2 log
likelihood values. Unconditional regression was
used to reduce the impact of our original selection
process for uninfected controls. That process was
influenced by procedure type and duration, both
of which are part of the NNIS risk score. Analyses
were performed with SAS software (SAS
Institute, Cary, NC), system for Windows, v6.12).
Results
The source population for cases and controls
was 9,037 patients who underwent 10,457
operative procedures. One hundred ninety-six
confirmed surgical site infections were identified
(infection rate 2.1%), and 392 matched controls60 Emerging Infectious Diseases Vol. 7, No. 1, January–February 2001
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Table 1. Characteristics of the study population
Variable Cases (n=191) Controls (n=372) p value   Odds ratio (95% CI)
Mean age (yrs)     51.2     51.5   NA          NA
Male sex (%)     91 (47.6)   182 (48.9)   NA          NA
NNIS wound class, con-       8 (4.2)     13 (3.5)   NA          NA
  taminated or infected (%)
Surgical   NA          NA
  speciality (%)
   General     54 (28.3)   107 (28.8)
   Cardiac     41 (21.5)     78 (21.0)
   Orthopedic     31 (16.2)     63 (16.9)
   Plastic     17 (8.9)     30 (8.1)
   Urologic     14 (7.3)     27 (7.3)
   Vascular     10 (5.2)     19 (5.1)
   Gynecologic       5 (2.6)     10 (2.7)
   Neurosurgical       4 (2.1)       8 (2.2)
   Other     15 (7.9)     30  (7.8)
General anesthesia (%)   132 (69.1)   222 (59.7)   0.004 2.19 (1.29,3.72)
Duration of surgery,   105 (55-211)     83 (40-154) <0.001a 1.75 (1.34,2,29)a
  minutes (IQR)
Emergent     11 (5.8)     10 (2.7)   0.07 2.21 (0.94,5.21)
  procedure (%)
ASA score (%)   0.002b 2.0   (1.4, 2.9)b
Missing     30 (15.7)     80 (21.5)
1     32 (16.8)     83 (22.3)
2     62 (32.5)   130 (34.9)
3     59 (30.9)     74 (19.9)
4       8 (4.2)       5 (1.4)
5       0       0
Chronic disease score
Median (IQR) 2,219 (1,101-5,673) 1,641 (809-3,588)   0.09          NA
aValues are for duration as a 6-level ordinal variable. Risk is per-unit increase in duration category.
bASA as a four-level ordinal variable, excluding missing values. Risk is per-unit increase in ASA category, missing values
excluded.
OR = odds ratio.
ASA = American Society of Anesthesiologists physical status scale;  IQR = Interquartile range.
were selected. Drug dispensing data for the full 6
months before surgery were not available for 15
patients (5 cases and 10 controls), who were
therefore excluded. If a case was excluded, its
matched controls were also excluded (an additional
10 patients were excluded by this criterion).
The final study group included 191 cases and
372 controls (Table 1). The groups were
comparable with regard to age (mean 51 years)
and sex. General anesthesia (as opposed to other
types of anesthesia) was associated with surgical
site infection (Table 1). Although procedure
duration was included in the multivariate
matching process, longer duration was associat-
ed with surgical site infection. Procedures
classified as emergency had borderline associa-
tion. Other recognized risk factors, such as
procedure type and NNIS wound class, were not
significantly associated with infection because of
the matching procedure that was used to select
uninfected controls. ASA score was associated
with infection, but chronic disease score was
marginally associated.
The relationships were calculated between
surgical site infection rates and ASA scores for
the 80% of patients for whom scores had been
assigned and between surgical site infection
rates and the chronic disease scores (Figure 1).
Patients with missing ASA scores were included
in the chronic disease score groupings. The risk
for surgical site infection increased with ASA
group scores. In this group of patients (selected so
that one third had a surgical site infection) 27.8%
of those with an ASA score of 1, representing 25%
of the study population, had surgical site
infections, while 61.5% of those with scores of 4,
representing 3% of the study population, had
infections. No patients had scores of 5.
For the chronic disease score groups, the
proportion with surgical site infections also61 Vol. 7, No. 1, January–February 2001 Emerging Infectious Diseases
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Figure 1 (A and B). Risk for surgical site infection in
groups proportionate to ASA groupings for both the
American Society of Anesthesiologists (ASA)-
physical status score (A) and chronic disease score
(B). The width of each bar is proportional to the
sample size in that particular group. The percentage
above each bar represents the proportion of persons
in the group with infection.
Table 2.
a. Relationships between chronic disease score, ASA score, and surgical site infection
  Cases Controls Unadjusteda Adjustedb
Variable  (n-191)  (n=372) p value OR (95% CI) p value OR (95% CI)
Chronic disease 55 (28.8) 60 (16.1) <0.001 2.6 (1.6-4.2) 0.001 2.6 (1.5-4.7)
  score >5,000 (%)
ASA >3 (%) 67(35.1)c 79 (21.2)d <0.001 3.1 (1.7-5.5) 0.03 2.0 (1.1-3.7)
aUnadjusted values are controlled for age, sex, and procedure duration because of the matching process used to select
uninfected subjects.
bAdjusted for chronic disease score >5,000, ASA >3, type of anesthesia, emergent nature of the procedure, procedure duration
(ordinal), and wound class.
cThirty (15.7%) cases had missing ASA scores.
dEighty-two (21.7%) controls had missing ASA scores.
ASA = American Society of Anesthesiologists; OR = odds ratio; CI = confidence intervals
b. Relationships between admission chronic disease score, chronic disease score, ASA score and surgical site infection
 Cases Controls Unadjusted Adjusteda
Variable  (n=51)  (n=67) p value OR (95% CI) p value OR (95% CI)
Admission chronic 18 (35)   5 (7) <0.001 6.8 (2.3-19.9) 0.003 6.2 (1.9-20.4)
  disease score
  >4,500 (%)
Chronic disease 22 (43) 17 (25)   0.05 2.2 (1.0-4.9) 0.32 1.6 (0.6-3.9)
  score >5,000 (%)
ASA >3 (%) 39 (83)b 36 (58)c   0.007 3.5 (1.4-8.8) 0.03 3.4 (1.1-10.2)
aAdjusted for sex, age, type of anesthesia, emergency nature of the procedure, procedure duration (ordinal) and wound class.
bFour cases had missing ASA scores.
cFive controls had missing ASA scores.
increased with the chronic disease group scores.
The group with the lowest 25% of the chronic
disease scores had a surgical site infection
proportion of 29.7%, while those with the highest
3% of scores had a surgical site infection
proportion of 40%. The ASA score and the chronic
disease score were strongly correlated (r=0.58,
p<0.001). One major breakpoint in surgical site
infection rates occurred between the lower 80%
the upper 20% of the chronic disease score values,
as determined by conditional logistic regression.
Therefore, the chronic disease score was
analyzed as a dichotomous variable, using a
breakpoint of chronic disease scores >5,000 and
<5000.
Relationships were calculated between surgi-
cal site infection and chronic disease scores
>5,000 and between surgical site infection and
ASA scores (Table 2a). In the unadjusted analysis
(but with data controlled for the original
matching variables of age, sex, and procedure
type), both the chronic disease score >5,000 and
ASA >3 were strong predictors of surgical site
infection (for chronic disease score, odds ratio
[OR] 2.6, 95% confidence interval [CI] 1.6-4.2,
p<0.001; for ASA, OR 3.1, 95% CI 1.7-5.5,
p<0.001). When added to a multivariate model62 Emerging Infectious Diseases Vol. 7, No. 1, January–February 2001
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Figure 2 (A, B, and C). Risk of surgical site infection in
different risk index categories. The width of each bar is
proportional to the sample size in that particular
group; A) shows the traditional National Nosocomial
Infection Surveillance (NNIS) risk index categories;
B) shows a modified NNIS risk index with chronic
disease score >5,000 substituted for ASA >3; C)
shows a modified NNIS risk index, incorporating
both chronic disease score >5,000 and the  traditional
NNIS risk index categories. In each group, the
percentage of patients with infections is shown.
that already included the ASA score and other
factors associated with surgical site infection, the
chronic disease score improved the explanatory
value of the model (p<0.001). In this model,
both ASA and the chronic disease score remained
significant predictors of surgical site infection
(chronic disease score >5000, OR 2.6, 95% CI 1.5-
4.7, p=0.001; ASA >3, OR 2.0, 95% CI 1.1-3.7,
p=0.03).
A chronic disease score based solely on
admission medications (admission chronic dis-
ease score) was also studied (Table 2b). From 191
total cases of surgical site infection and 372
uninfected controls, cases with admission and
surgery on the same day were excluded, leaving
51 cases and 67 controls. The median admission
chronic disease score for cases was 2,218
(interquartile range [IQR] 1,285-4,818) and for
controls was 1,285 (IQR 1,209-2,729) (p=0.008,
Wilcoxon rank sum test). The admission chronic
disease score was correlated with the 6-month
chronic disease score (p<0.001, r=0.45) and with
the ASA score (p=0.02, r=0.22). The admission
chronic disease score was analyzed as a
dichotomous variable, using a breakpoint of
chronic disease score >4,500 and chronic disease
score <4,500. Admission chronic disease score
>4,500, chronic disease score >5,000 and ASA >3
were all associated with surgical site infection;
the association was strongest for the admission
chronic disease score (for admission chronic
disease score, OR 6.8, p<0.001; for the 6-month
chronic disease score, OR 2.2, p=0.05; for ASA,
OR 3.5, p=0.007).
After the data were controlled for anesthesia
type, emergency nature of surgery, sex, age,
procedure duration, and wound class by logistic
regression, the model that included the admis-
sion chronic disease score had better predictive
value for surgical site infection than the model
containing the chronic disease score based on 6
months of preoperative medications (p<0.01) and
the model that included the ASA score (p<0.03).
In these multivariate models, the admission
chronic disease score was a stronger predictor of
surgical site infection than the chronic disease
score based on 6 months of preoperative
medications and the ASA score (for the admission
chronic disease score, OR 6.2, p=0.003; for the 6-
month chronic disease score, OR 1.6, p=0.32; for
ASA score, OR 3.4, p=0.03); the ASA score did not
improve the model already containing the
admission chronic disease score (p=0.1).
In this population, the NNIS risk index was
correlated with infection status (Figure 2A). As
the risk index score increased, the proportion of
infected patients increased (27% for a risk score
of 0, 100% for a risk score of 3). Both the risk index
that substituted the chronic disease score for the
ASA score (Figure 2B) and the risk index that
added the chronic disease score to the
conventional NNIS score (Figure 2C) increased
progressively in the proportion infected in each
risk class. After the data were controlled for type63 Vol. 7, No. 1, January–February 2001 Emerging Infectious Diseases
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of anesthesia used and emergency nature of the
surgery, the risk index that included a chronic
disease score >5,000 in place of ASA >3 (Figure
2B) was a stronger predictor of surgical site
infection than the traditional NNIS score (Figure
2A) (p<0.05). The risk index that included both a
chronic disease score >5,000 and an ASA >3
(Figure 2C) was a better predictor of surgical site
infection than both the traditional risk score
(p<0.001) and the score that substituted the
chronic disease score for an ASA >3 (p<0.01).
Conclusions
The chronic disease score, like the ASA score
when other known risk factors for infection were
taken into consideration, was a strong predictor
of postoperative surgical site infection. The
strength of the association between the ASA
score and the chronic disease score was
impressive since the two scores are derived by
completely different methods. The chronic
disease score performed comparably with the
ASA score as a component of the NNIS risk index,
and an NNIS-like index based on both the chronic
disease and ASA scores performed better than
the conventional NNIS index. In our limited
sample of patients who were admitted to the
hospital before the day of surgery, a chronic
disease score based solely on medications
dispensed on the day of admission was a stronger
predictor of surgical site infection than either the
ASA or 6-month chronic disease scores. Thus,
either the 6-month or admission chronic disease
scores might be considered as an alternative to
the ASA score and may provide better risk
stratification.
Compared with the ASA score, the chronic
disease score has several potential advantages as
a risk-adjuster for surgical site infection. It is
objective and, since it can be calculated from the
administrative databases of health insurance
organizations, sometimes more readily available
than the ASA score. Pharmacy databases are
often the most complete and accurate ones
maintained by health plans, and the information
in these systems is usually easy to interpret. In
addition, pharmacy data can often be obtained
from third parties, such as pharmacy benefit
managers, or directly from the pharmacies where
prescriptions were filled.
Since the chronic disease score can be derived
from electronic pharmacy data, it lends itself to
use as a risk-adjuster in automated systems for
monitoring surgical site infection, particularly in
patients discharged from the hospital who do not
return to the hospital for care. Such systems
would be applicable not only for the surveillance
and risk adjustment of surgical site infection
rates for individual hospitals, but also for larger
populations such as members of a health
maintenance organization or other health
insurance group. The chronic disease score based
solely on admission medications might be
attractive for use in hospital-based surveillance
systems if the results in this study are
reproducible in larger patient populations.
This study had some limitations. Since age is
a component of the chronic disease score and
cases were matched to controls by age, the
observed association between the chronic disease
score and surgical site infection may be
underestimated. In addition, because compo-
nents of the NNIS risk index were used to match
uninfected controls to cases, our results may
underestimate the associations between surgical
site infection and the traditional NNIS risk
index, the risk index using the chronic disease
score in place of an ASA score, and the index
incorporating both the chronic disease and ASA
scores. Additionally, all the procedures were
performed at a single hospital, increasing the
likelihood that ASA scores were assigned more
consistently than in the population at large. Such
an effect would have overestimated the utility of
the ASA score. Restriction to a single institution
may also affect the generalizability of these
results. Although we do not have a ready
explanation for ways in which the chronic disease
score could have a special relationship to
infection in this population, our findings should
be tested in other settings. Our relatively limited
sample size precludes investigation of whether
the chronic disease score performed differently
for different types of procedures or specific
groups of patients. Validation of our model in a
larger population with a more diverse set of
procedure types would be worthwhile. Finally,
the chronic disease score can only be assessed
readily for patients whose pharmacy dispensing
data are available. This information exists for
most patients through pharmacy benefit sys-
tems, but few hospitals have ready access to this
information.
Aspects of the association between chronic
disease score and surgical site infection that
warrant additional exploration include assessing64 Emerging Infectious Diseases Vol. 7, No. 1, January–February 2001
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the value of the chronic disease score, either
alone or in addition to the ASA score for specific
procedure types, and developing new weights for
the chronic disease categories to improve
predictive value. Evaluation of a chronic disease
score based on admission medications using a
larger sample size than the one used in this study
and including patients from multiple institutions
would be of interest.
In summary, the chronic disease score
provides a useful risk-adjuster for surgical site
infection. It is objective and can often be obtained
from automated information available from
standard health insurance claims data. It may be
available when the ASA score is not, so it could be
used either in place of the ASA score or in
addition to it. Further investigation of the chronic
disease score and its association with surgical
site infection is warranted.
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